Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2021 · 10-Q
Revenue$4.57M$4.57M+30.0% vs Q3 2020 Net Income-$3.98M-$3.98MN/M vs Q3 2020 EPS Diluted-$0.18-$0.18N/M vs Q3 2020 Gross Profit$3,041,000+16.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,296,000N/M Free Cash Flowderived-$3,421,000— Margins · derivedGross margin66.5%−7.9 pt vs Q3 2020
Operating margin-83.2%−47.0 pt vs Q3 2020
Net margin-87.0%−44.8 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end